Annual SG&A
$22.84 M
+$2.62 M+12.97%
31 December 2023
Summary:
Galera Therapeutics annual selling, general & administrative expenses is currently $22.84 million, with the most recent change of +$2.62 million (+12.97%) on 31 December 2023. During the last 3 years, it has risen by +$7.13 million (+45.38%). GRTX annual SG&A is now at all-time high.GRTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.78 M
-$310.00 K-10.04%
30 June 2024
Summary:
Galera Therapeutics quarterly selling, general & administrative expenses is currently $2.78 million, with the most recent change of -$310.00 thousand (-10.04%) on 30 June 2024. Over the past year, it has dropped by -$2.21 million (-44.35%). GRTX quarterly SG&A is now -69.94% below its all-time high of $9.25 million, reached on 30 June 2023.GRTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.76 B
-$29.11 M-1.68%
30 June 2024
Summary:
Galera Therapeutics TTM selling, general & administrative expenses is currently -$1.76 billion, with the most recent change of -$29.11 million (-1.68%) on 30 June 2024. Over the past year, it has dropped by -$1.78 billion (-6891.12%). GRTX TTM SG&A is now -1576.03% below its all-time high of $25.87 million, reached on 30 September 2023.GRTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.0% | -44.4% | -6891.1% |
| 3 y3 years | +45.4% | -49.4% | -8888.3% |
| 5 y5 years | +308.4% | +53.0% | -10000.0% |
GRTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +45.4% | -69.9% | +39.9% | -64.8% | at low |
| 5 y | 5 years | at high | +308.4% | -69.9% | +53.0% | -363.3% | at low |
| alltime | all time | at high | +552.5% | -69.9% | +123.2% | -1576.0% | at low |
Galera Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $2.78 M(-10.0%) | $12.85 M(-33.5%) |
| Mar 2024 | - | $3.09 M(+55.5%) | $19.32 M(-15.4%) |
| Dec 2023 | $22.84 M(+13.0%) | $1.99 M(-60.2%) | $22.84 M(-11.7%) |
| Sept 2023 | - | $4.99 M(-46.0%) | $25.87 M(+0.5%) |
| June 2023 | - | $9.25 M(+39.9%) | $25.73 M(+18.2%) |
| Mar 2023 | - | $6.61 M(+31.6%) | $21.78 M(+7.7%) |
| Dec 2022 | $20.21 M(-3.5%) | $5.02 M(+3.5%) | $20.21 M(-1.3%) |
| Sept 2022 | - | $4.85 M(-8.3%) | $20.48 M(-3.0%) |
| June 2022 | - | $5.29 M(+4.9%) | $21.11 M(+0.8%) |
| Mar 2022 | - | $5.05 M(-4.5%) | $20.94 M(-0.1%) |
| Dec 2021 | $20.95 M | $5.28 M(-3.7%) | $20.95 M(+4.8%) |
| Sept 2021 | - | $5.49 M(+7.1%) | $19.99 M(+8.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $5.12 M(+1.3%) | $18.45 M(+7.3%) |
| Mar 2021 | - | $5.06 M(+17.0%) | $17.20 M(+9.5%) |
| Dec 2020 | $15.71 M(+87.9%) | $4.32 M(+9.6%) | $15.71 M(+10.0%) |
| Sept 2020 | - | $3.94 M(+1.8%) | $14.28 M(+17.5%) |
| June 2020 | - | $3.87 M(+8.6%) | $12.15 M(+21.1%) |
| Mar 2020 | - | $3.57 M(+23.3%) | $10.03 M(+20.0%) |
| Dec 2019 | $8.36 M(+49.5%) | $2.89 M(+59.3%) | $8.36 M(+15.9%) |
| Sept 2019 | - | $1.82 M(+3.4%) | $7.21 M(+8.6%) |
| June 2019 | - | $1.76 M(-7.3%) | $6.64 M(+35.9%) |
| Mar 2019 | - | $1.89 M(+8.5%) | $4.88 M(+63.3%) |
| Dec 2018 | $5.59 M(+59.8%) | $1.75 M(+40.2%) | $2.99 M(+140.2%) |
| Sept 2018 | - | $1.25 M | $1.25 M |
| Dec 2017 | $3.50 M | - | - |
FAQ
- What is Galera Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Galera Therapeutics?
- What is Galera Therapeutics annual SG&A year-on-year change?
- What is Galera Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Galera Therapeutics?
- What is Galera Therapeutics quarterly SG&A year-on-year change?
- What is Galera Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Galera Therapeutics?
- What is Galera Therapeutics TTM SG&A year-on-year change?
What is Galera Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of GRTX is $22.84 M
What is the all time high annual SG&A for Galera Therapeutics?
Galera Therapeutics all-time high annual selling, general & administrative expenses is $22.84 M
What is Galera Therapeutics annual SG&A year-on-year change?
Over the past year, GRTX annual selling, general & administrative expenses has changed by +$2.62 M (+12.97%)
What is Galera Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of GRTX is $2.78 M
What is the all time high quarterly SG&A for Galera Therapeutics?
Galera Therapeutics all-time high quarterly selling, general & administrative expenses is $9.25 M
What is Galera Therapeutics quarterly SG&A year-on-year change?
Over the past year, GRTX quarterly selling, general & administrative expenses has changed by -$2.21 M (-44.35%)
What is Galera Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of GRTX is -$1.76 B
What is the all time high TTM SG&A for Galera Therapeutics?
Galera Therapeutics all-time high TTM selling, general & administrative expenses is $25.87 M
What is Galera Therapeutics TTM SG&A year-on-year change?
Over the past year, GRTX TTM selling, general & administrative expenses has changed by -$1.78 B (-6891.12%)